JP2006525990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006525990A5 JP2006525990A5 JP2006506603A JP2006506603A JP2006525990A5 JP 2006525990 A5 JP2006525990 A5 JP 2006525990A5 JP 2006506603 A JP2006506603 A JP 2006506603A JP 2006506603 A JP2006506603 A JP 2006506603A JP 2006525990 A5 JP2006525990 A5 JP 2006525990A5
- Authority
- JP
- Japan
- Prior art keywords
- isoxazol
- amide
- phenyl
- pentanoic acid
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US47000203P | 2003-05-12 | 2003-05-12 | |
| PCT/IB2004/001478 WO2004099200A1 (en) | 2003-05-12 | 2004-05-10 | Isoxazole and isothiazole compounds for the treatment of neurodegenerative disorders |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006525990A JP2006525990A (ja) | 2006-11-16 |
| JP2006525990A5 true JP2006525990A5 (enExample) | 2007-05-31 |
Family
ID=33435258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006506603A Withdrawn JP2006525990A (ja) | 2003-05-12 | 2004-05-10 | 神経変性障害の処置のためのイソオキサゾール化合物およびイソチアゾール化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7241786B2 (enExample) |
| EP (1) | EP1636220A1 (enExample) |
| JP (1) | JP2006525990A (enExample) |
| BR (1) | BRPI0409721A (enExample) |
| CA (1) | CA2524511A1 (enExample) |
| MX (1) | MXPA05012196A (enExample) |
| WO (1) | WO2004099200A1 (enExample) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7763609B2 (en) | 2003-12-15 | 2010-07-27 | Schering Corporation | Heterocyclic aspartyl protease inhibitors |
| DK1730119T3 (da) * | 2004-03-23 | 2008-08-11 | Pfizer Prod Inc | Imidazolforbindelser til behandling af neurodegenerative forstyrrelser |
| US7244757B2 (en) | 2004-04-01 | 2007-07-17 | Pfizer Inc | Pyrazole-amine compounds for the treatment of neurodegenerative disorders |
| US7220865B2 (en) * | 2004-04-01 | 2007-05-22 | Pfizer Inc | Isoxazole-and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| KR20080040010A (ko) * | 2005-09-22 | 2008-05-07 | 화이자 프로덕츠 인코포레이티드 | 신경계 질환 치료용 이미다졸 화합물 |
| EP2081905B1 (en) | 2006-07-28 | 2012-09-12 | Boehringer Ingelheim International GmbH | Sulfonyl compounds which modulate the cb2 receptor |
| MX2009002888A (es) | 2006-09-25 | 2009-03-31 | Boehringer Ingelheim Int | Compuestos que modulan el receptor cb2. |
| WO2009061652A1 (en) | 2007-11-07 | 2009-05-14 | Boehringer Ingelheim International Gmbh | Compounds which modulate the cb2 receptor |
| US8957063B2 (en) | 2008-02-21 | 2015-02-17 | Boehringer Ingelheim International Gmbh | Amine and ether compounds which modulate the CB2 receptor |
| EP2326629B1 (en) | 2008-07-10 | 2013-10-02 | Boehringer Ingelheim International GmbH | Sulfone compounds which modulate the cb2 receptor |
| NZ591111A (en) | 2008-09-25 | 2013-08-30 | Boehringer Ingelheim Int | Sulfonyl compounds which selectively modulate the cb2 receptor |
| WO2010096371A2 (en) | 2009-02-18 | 2010-08-26 | Boehringer Ingelheim International Gmbh | Heterocyclic compounds which modulate the cb2 receptor |
| US8299103B2 (en) * | 2009-06-15 | 2012-10-30 | Boehringer Ingelheim International Gmbh | Compounds which selectively modulate the CB2 receptor |
| US8383615B2 (en) | 2009-06-16 | 2013-02-26 | Boehringer Ingelheim International Gmbh | Azetidine 2-carboxamide derivatives which modulate the CB2 receptor |
| EP2480544A1 (en) | 2009-09-22 | 2012-08-01 | Boehringer Ingelheim International GmbH | Compounds which selectively modulate the cb2 receptor |
| EP2523936A1 (en) | 2010-01-15 | 2012-11-21 | Boehringer Ingelheim International GmbH | Compounds which modulate the cb2 receptor |
| WO2011109324A1 (en) | 2010-03-05 | 2011-09-09 | Boehringer Ingelheim International Gmbh | Tetrazole compounds which selectively modulate the cb2 receptor |
| JP5746764B2 (ja) | 2010-07-22 | 2015-07-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｃｂ２受容体を調節する化合物 |
| AR091516A1 (es) | 2012-06-22 | 2015-02-11 | Actelion Pharmaceuticals Ltd | Derivados de 1-[m-carboxamido(hetero)aril-metil]-heterociclil-carboxamida |
| EP2803668A1 (en) | 2013-05-17 | 2014-11-19 | Boehringer Ingelheim International Gmbh | Novel (cyano-dimethyl-methyl)-isoxazoles and -[1,3,4]thiadiazoles |
| GB201820166D0 (en) * | 2018-12-11 | 2019-01-23 | Ucb Biopharma Sprl | Therapeutic agents |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2102890A1 (en) * | 1991-05-28 | 1992-11-29 | Soumya P. Sahoo | Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| DE69329425T2 (de) * | 1992-12-16 | 2001-01-18 | Basf Ag | Dolastatin analog |
| AU6229699A (en) * | 1998-10-26 | 2000-05-15 | Sumitomo Pharmaceuticals Company, Limited | Beta-amyloid formation inhibitors |
| AR039059A1 (es) * | 2001-08-06 | 2005-02-09 | Sanofi Aventis | Compuesto derivado de acilaminotiazol, su utilizacion, procedimientos para prepararlo, composicion farmaceutica que lo comprende, y compuestos intermediarios |
| WO2003064396A1 (en) * | 2002-02-01 | 2003-08-07 | Elan Pharmaceuticals, Inc. | Hydroxyalkanoyl aminopyrazoles and related compounds |
| BR0314611A (pt) * | 2002-10-09 | 2005-07-26 | Pfizer Prod Inc | Compostos de tiazol para o tratamento de distúrbios neurodegenerativos |
| EP1551809A1 (en) * | 2002-10-09 | 2005-07-13 | Pfizer Products Inc. | Pyrazole compounds for treatment of neurodegenerative disorders |
-
2004
- 2004-05-10 WO PCT/IB2004/001478 patent/WO2004099200A1/en not_active Ceased
- 2004-05-10 CA CA002524511A patent/CA2524511A1/en not_active Abandoned
- 2004-05-10 BR BRPI0409721-1A patent/BRPI0409721A/pt not_active IP Right Cessation
- 2004-05-10 MX MXPA05012196A patent/MXPA05012196A/es unknown
- 2004-05-10 EP EP04731965A patent/EP1636220A1/en not_active Withdrawn
- 2004-05-10 JP JP2006506603A patent/JP2006525990A/ja not_active Withdrawn
- 2004-05-12 US US10/843,939 patent/US7241786B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006525990A5 (enExample) | ||
| CA2039056C (en) | 3,5-di-tertiarybutyl-4-hydroxyphenylmethylene derivatives of 2-substituted thiazolidinones, oxazolidinones, and imidazolidinones as antiinflammatory agents | |
| EP1551815A1 (en) | Thiazole compounds for the treatment of neurodegenerative disorders | |
| RU2049784C1 (ru) | Гетероциклические производные или их соли с кислотами или основаниями | |
| KR20170082577A (ko) | 치환된 피라졸로(1,5-a)피리미딘 및 의학적 장애의 치료에서의 그의 용도 | |
| JP2010501587A5 (enExample) | ||
| WO2002102778A1 (en) | Phenylpyridine carbonyl piperazine derivative | |
| FR2587342A1 (fr) | Nouveaux derives du thiazole, leur preparation et leur utilisation en therapeutique | |
| JP2005509024A5 (enExample) | ||
| RU2008136553A (ru) | Производные бензотиазола в качестве агонистов бета2 адренорецептора | |
| JPH01143856A (ja) | 抗アレルギーおよび抗炎症剤用２−アリール置換複素環式化合物 | |
| RU2004117887A (ru) | Ариланилиновые агонисты бета2 адренергических рецепторов | |
| JPWO1998054153A1 (ja) | 新規な環状ジアミン化合物及びこれを含有する医薬 | |
| EP3442948B1 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| JP2011526594A5 (enExample) | ||
| RU2006137272A (ru) | Производные 2-фенилпропионовой кислоты и содержащие их фармацевтические композиции | |
| JP2008506691A (ja) | エストロゲン関連受容体−アルファに媒介される疾患の処置のためのアリーリデン | |
| JP2020517677A5 (enExample) | ||
| FR2934995A1 (fr) | Composes d'azetidines polysubstitues, leur preparation et leur application en therapeutique | |
| WO2008150492A1 (en) | Tricyclic inhibitors of fatty acid amide hydrolase | |
| JP2007261945A (ja) | チアゾール誘導体 | |
| JP2006525990A (ja) | 神経変性障害の処置のためのイソオキサゾール化合物およびイソチアゾール化合物 | |
| JP3352184B2 (ja) | ピペラジン不飽和脂肪酸誘導体 | |
| CN101128451A (zh) | N-[(4,5-二苯基-2-噻吩基)甲基]胺衍生物、它们的制备与治疗用途 | |
| RU2007103304A (ru) | Новые производные гексафторизопропанола |